Abstract
We carried out a retrospective incidence, prevalence and mortality survey of myasthenia gravis in the province of Reggio Emilia in Northern Italy. Based on 49 patients, the mean incidence per year for the period 1980 through 1994 was 7.8 per 1,000,000. On 31 December 1994 the prevalence rate was 117.5 per 1,000,000 for all patients, either active or recovered (50 cases in a population of 427,493) and 103.4 per 1,000,000 for the active disease. In the 15-year period 1980–1994 the average mortality rate was 1.0 per 1,000,000 per year. The average age at onset was 44.6 ± 21.0, and the average age at the time of prevalence determination was 51.1 ± 19.6 for the active disease. At the time of diagnosis, 21 patients (36.8%) were classed in group I according to Osserman's criteria, 31 in group II (54.4%), (19 in group II-A and 12 in group II-B), and the other 5 (8.8%) in group III. Of all the prevalence cases, 6 (12%) were in remission without therapy and 6 with therapy, while most of the others 16 (32%) were classed in group I, 15 (30%) in group II, and 1 (2%) in group III. Thymectomy was performed in 20 patients (35.1%), 12 (21%) had thymoma (malignant in 4 cases), 6 had thymic hyperplasia while in two patients thymic histology was normal. The relation the grade of Osserman's scale at the time of incidence and the presence of thymoma were significant. Higher grades of Osserman's scale were associated were malignant thymoma. Furthermore the relationship between thymectomy and the grade of Osserman's scale at the date of prevalence was significant for the presence of lower grades of Osserman's scale in the patients submitted to thymectomy.
Similar content being viewed by others
References
Drachmann DB, De Silva S, Ramsay D, Pestronk A. Humoral pathogenesis of myasthenia gravis. Ann NY Acad Sci 1987; 505: 90–105.
Ravitis J. Myasthenia gravis. A well-understood neuromuscular disorder. Postgraduate Medicine 1988; 83: 219–223.
Kurland LT, Alter M. Current status of the epidemiology and genctics of myasthenia gravis. In: Viets HR (ed), Myastenia gravis. Springfield, Illinois: Charles C. Thomas Publisher, 1961: 307–336.
Sorensen TT, Holm E-V. Myasthenia gravis in the Country of Viborg, Denmark. Eur Neurol 1989; 29: 177–179.
Garland H, Clark ANG. Myasthenia gravis: A personal study of 60 cases. Br Med J 1956; 1: 1259–1262.
Somnier FE, Keiding N, Paulson OB. Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey. Arch Neurol 1991; 48: 733–739.
Kurtzke JF. Epidemiology of myasthenia gravis. In: Schoenberg BS (ed), Advances in neurology, Vol. 19. New York: Raven Press, 1978: 545–566.
Giagheddu M, Puggioni G, Sanna G, et al. Epidemiological study of myasthenia gravis in Sardinia, Italy (1958–1986). Acta Neurol Scand 1989; 79: 326–333.
Tola MR, Granieri E, Paolino E, et al. Epidemiological study of myasthenia gravis in the province of Ferrara, Italy. J Neurol 1989; 236: 38–390.
D'Alessandro R, Granieri E, Benassi G, Tola MR, et al. Comparative study on the prevalence of myasthenia gravis in the provinces of Bologna and Ferrara, Italy. Acta Neurol Scand 1991; 83: 83–88.
Aiello I, Pastorino M, Sotgiu S, Pirastru MI, Sau GF, et al. Epidemiology of Myasthenia gravis in the Northwestern Sardinia. Neurocpidemiology 1997; 16: 199–206.
Ferrari G, Lovaste MG. Epidemiology of myasthenia gravis in the province of Trento (northern Italy). Neuroepidemiology 1992; 11: 135–142.
Guidetti D, Cavalletti S, Merelli E, et al. Epidemiological survey of multiple sclerosis in the provinces of Reggio Emilia and Modena. Neuroepidemiology 1995; 14: 7–13.
Guidetti D, Bondavalli M, Sabadini R, et al. Epidemiological survey of amyotrophic lateral sclerosis in the province of Reggio Emilia, Italy. Influence of environmental exposure to lead. Neuroepidemiology 1996; 15: 301–312.
Angelini C, Sartori V. Miastenia grave autoimmune. In: Angelini C (ed), Le malattic neuromuscolari. Padova: Piccin Press, 1994: 209–222.
D'Alessandro R, Casmiro M, Benassi G, et al. A reliable disability scale for myasthenia gravis sensitive to clinical changes. Acta Neurol Scand 1995; 92: 77–82.
Osserman KE, Genkins G. Studies in myasthenia gravis: Review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 1971; 38: 497–537.
Schoenberg BS. Calculating confidence intervals for rates and ratio. Simplified method utilizing tabular values based on the Poisson distribution. Neuroepidemiology 1983; 2: 257–265.
Armitage P. Tests for linear trends in proportion and frequencies. Biometrics 1955; 11: 375–378.
Treves TA, Rocca WA, Meneghini F. Epidemiology of myasthenia gravis in neuroepidemiology. In: Anderson DW, Schoenberg DG (eds), A tribute to Bruce Schoenberg. Boston: CRC Press Boston, 1991: 297–309.
Christensen PB, Jensen TS, Tsiropoulos I, et al. Associated autoimmune disease in myasthenia gravis. Acta Neurol Scand 1995; 91: 192–195.
Oosterhuis HJGH. The natural course of myasthenia gravis: A long term follow up study. J Neurol Neurosurg Psychiatry 1989; 52: 1121–1127.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Guidetti, D., Sabadini, R., Cavalletti, S. et al. Epidemiological study of myasthenia gravis in the province of Reggio Emilia, Italy. Eur J Epidemiol 14, 381–387 (1998). https://doi.org/10.1023/A:1007449221638
Issue Date:
DOI: https://doi.org/10.1023/A:1007449221638